News | News By Subject | News by Disease News By Date | Search News

Chronic obstructive pulmonary disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
GlaxoSmithKline (GSK) Terminates Development of Losmapimod for COPD     10/26/2016
Theravance Biopharma (TBPH) Touts Significant Data from Pivotal Phase III FULFIL Study     9/8/2016
AstraZeneca PLC (AZN) Announces Positive Top-Line Data From Two Phase III SYMBICORT Studies     8/10/2016
Verona Pharma (VRP.L) Rakes in $63.3 Million to Help Progress COPD Candidate RPL554     6/21/2016
GlaxoSmithKline (GSK) Eyes Lead in Triple Lung Drug Market with Early 2016 Filing Plan     6/2/2016
After Initial Miss, GlaxoSmithKline (GSK)'s Pioneering Lung Study Shows Positive Results     5/24/2016
AstraZeneca PLC (AZN) Snaps Up All Rights to Orexo (ORXOF)'s OX-CLI Project     3/17/2016
Investors Hold Their Breath for Data from Aduro Biotech (ADRO), Novartis AG (NVS)     3/11/2016
FDA Approves Novartis AG (NVS)'s Dual Combination Bronchodilator for COPD     10/30/2015
Boehringer Ingelheim and BioMed X Establish Team of Scientists for IDing Key Epigenetic Regulators of COPD     9/21/2015
GlaxoSmithKline (GSK), Theravance (THRX)'s Breo Fails to Extend Lives in Ambitious Study     9/10/2015
AstraZeneca PLC (AZN) Two-in-One Lung Drug Succeeds in Phase III Trial     3/19/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Mylan (MYL), Theravance (THRX) Partner Up for $265 Million COPD Pact     2/2/2015
Novartis AG (NVS) Submits Two Lung Drugs for FDA Approval; Analysts Question Decision     1/8/2015

News from Around the Web
3M Drug Delivery Systems Designs An "Intelligent Inhaler" System For COPD, Asthma And Other Respiratory Ills     4/26/2016
New Links Between Lung Disease And Smoking Behavior Discovered, University of Nottingham Reveals     9/29/2015
Tai Chi Linked To Improved Physical Capacity In Certain Common Long Term Conditions, BMJ Reveals     9/18/2015
The Scripps Research Institute Scientists Create Mimic Of "Good" Cholesterol To Fight Heart Disease And Stroke     10/10/2014
Long-Term Use of Vitamin E May Cut COPD Risk, Cornell University and Brigham and Women's Hospital Study Finds     6/16/2011
Certain COPD Meds Linked to Urinary Troubles in Men, St. Michael's Hospital Study     5/24/2011
Chinese Herbal Paste May Help Prevent Exacerbations of COPD, Gunag'anmen Hospital Study     5/23/2011
Vitamin D Improves Exercise Outcomes in Patients with COPD, Katholieke Universiteit Leuven Study Shows     5/16/2011
Inhaled Meds May Save COPD/Pneumonia Patients' Lives, Veterans Evidence Study     4/21/2011
Spiriva Beats Serevent for COPD Flare-ups, University Hospital Giessen and Marburg GmbH Study     3/24/2011
Airway Mucus Buster, Amygdala Size Matters, University of Texas Study     1/3/2011
Team Treatment Helps Depression, Chronic Disease, University of Washington Study     12/30/2010
Once-a-Day Beta Agonist Works in COPD, Clinical Research Study Finds     11/3/2010
Early Antibiotic Treatment for Severe COPD Symptoms Linked With Improved Outcomes, Baystate Medical Center Study     5/26/2010
Beta-Blockers May Benefit COPD, University Medical Center Utrecht Study     5/25/2010

Press Releases
Theravance Biopharma (TBPH) Highlights Filing Of EU Regulatory Submission For The Closed Triple In COPD By GlaxoSmithKline (GSK) And Innoviva     12/5/2016
GlaxoSmithKline (GSK) Release: Relvar Ellipta 100/25 mcg Gains Approval In Japan For Use In Patients With COPD     12/2/2016
GlaxoSmithKline (GSK) Files Regulatory Submission In European Union For Once-Daily Closed Triple Combination Therapy FF/UMEC/VI For Patients With COPD     12/2/2016
Theravance Biopharma (TBPH) Highlights Filing Of U.S. New Drug Application For The Closed Triple In COPD By GlaxoSmithKline (GSK) And Innoviva     11/22/2016
GlaxoSmithKline (GSK) Files Regulatory Submission In US For Once-Daily Closed Triple Combination Therapy FF/UMEC/VI For Patients With COPD     11/21/2016
GlaxoSmithKline (GSK) Files Regulatory Submission In U.S. For Once-Daily Closed Triple Combination Therapy FF/UMEC/VI For Patients With COPD     11/21/2016
Boehringer Ingelheim Welcomes Central Role Of LAMA/LABA Therapy Within 2017 GOLD Strategy For COPD     11/16/2016
Sunovion Recognizes Epilepsy And COPD Awareness Months In The U.S. During November     11/1/2016
Trudell Medical International: Non-Drug Device Helps Reduce Antibiotic And Oral Corticosteroids Usage Following COPD Exacerbations     10/27/2016
Theravance Biopharma (TBPH) And Mylan (MYL) Announce Positive Results From Two Pivotal Phase 3 Studies Of Revefenacin (TD-4208) For The Treatment Of Chronic Obstructive Pulmonary Disease (COPD)     10/20/2016
The American College of Chest Physicians And Sunovion Announce Strategic Initiative Focused On The Importance Of Drug Delivery In The Management Of COPD     10/20/2016
Boehringer Ingelheim Release: New Data Analyses Provide Insights That May Help Predict COPD Exacerbation Risk     10/17/2016
Sunovion Announces FDA Filing Acceptance Of New Drug Application For SUN-101/Eflow For The Treatment Of Patients With Chronic Obstructive Pulmonary Disease (COPD)     10/13/2016
BioCorp Launches Inspair, The Smart Sensor To Convert Inhalers Into Connected Devices To Help Patients With Asthma Or Chronic Obstructive Pulmonary Diseases (COPD)     10/6/2016
Angionetics' Generx [Ad5fgf-4] Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease     9/12/2016

//-->